Evidence map›Paper›PMID 40461695›Full record

ArticleCommunications medicine2025

Patient-specific prostate segmentation in kilovoltage images for radiation therapy intrafraction monitoring via deep learning.

Adam Mylonas, Zeyao Li, Marco Mueller, Jeremy T Booth, Ryan Brown, Mark Gardner, Andrew Kneebone, Thomas Eade, Paul J Keall, Doan Trang Nguyen

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Deep learning-based prediction of interfractional anatomic variations in prostate cancer radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adam MylonasImage X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. adam.mylonas@sydney.edu.au.ORCID http://orcid.org/0000-0001-6941-383X
Zeyao LiImage X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Marco MuellerImage X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Jeremy T BoothInstitute of Medical Physics, School of Physics, The University of Sydney, Sydney, NSW, Australia.
Ryan BrownNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Mark GardnerImage X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-4340-2547
Andrew KneeboneNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Thomas EadeNorthern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Paul J KeallImage X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Doan Trang NguyenImage X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Funding

Cancer Australia PdCCRS grant (2010923)Cancer Institute NSW (Cancer Institute New South Wales) Translational Program Grant (TPG2165)Department of Health | National Health and Medical Research Council (NHMRC) Investigator Grant (1194004)
6 · The paper itself

Abstract

backgroundDuring radiation therapy, the natural movement of organs can lead to underdosing the cancer and overdosing the healthy tissue, compromising treatment efficacy. Real-time image-guided adaptive radiation therapy can track the tumour and account for the motion. Typically, fiducial markers are implanted as a surrogate for the tumour position due to the low radiographic contrast of soft tissues in kilovoltage (kV) images. A segmentation approach that does not require markers would eliminate the costs, delays, and risks associated with marker implantation.

methodsWe trained patient-specific conditional Generative Adversarial Networks for prostate segmentation in kV images. The networks were trained using synthetic kV images generated from each patient's own imaging and planning data, which are available prior to the commencement of treatment. We validated the networks on two treatment fractions from 30 patients using multi-centre data from two clinical trials.

resultsHere, we present a large-scale proof-of-principle study of x-ray-based markerless prostate segmentation for globally available cancer therapy systems. Our results demonstrate the feasibility of a deep learning approach using kV images to track prostate motion across the entire treatment arc for 30 patients with prostate cancer. The mean absolute deviation is 1.4 and 1.6 mm in the anterior-posterior/lateral and superior-inferior directions, respectively.

conclusionsMarkerless segmentation via deep learning may enable real-time image guidance on conventional cancer therapy systems without requiring implanted markers or additional hardware, thereby expanding access to real-time adaptive radiation therapy.

Identifiers

PMID40461695
PMCPMC12134301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.